Evidence map›Paper›PMID 28508067›Full record

ArticleScience advances2017

Cryo-EM structure of human adenovirus D26 reveals the conservation of structural organization among human adenoviruses.

Xiaodi Yu, David Veesler, Melody G Campbell, Mary E Barry, Francisco J Asturias, Michael A Barry, Vijay S Reddy

Abstract read
In one paragraph

Article in Science advances, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Mysteries of adenovirus packaging.Journal of virology · 2025
    Review
  6. Article
  7. Review
  8. Illuminating the "Twilight Zone": Advances in Difficult Protein Modeling.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Journal of virology · 2022
    Article
  14. Article
  15. Viral vector-based gene therapies in the clinic.Bioengineering & translational medicine · 2022
    Review
  16. Article
  17. Review
  18. Adenovirus Structure: What Is New?International journal of molecular sciences · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaodi YuDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
David VeeslerDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Melody G CampbellDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Mary E BarryDivision of Infectious Diseases, Mayo Clinic, Rochester, MN 55902, USA.
Francisco J AsturiasDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Michael A BarryDivision of Infectious Diseases, Mayo Clinic, Rochester, MN 55902, USA.
Vijay S ReddyDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Funding

TRD #3: An automated and streamlined pipeline for in-situ molecular microscopyP41GM103310 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI DE MARCO, ALEX, KIEFT, JEFFREY S · 2012 to 2021
$14.7M
STRUCTURAL STUDIES OF EUKARYOTIC TRANSCRIPTIONR01GM067167 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI ASTURIAS, FRANCISCO J · 2003 to 2025
$9.2M
X-ray diffraction analysis of human adenovirusesR01AI070771 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI REDDY, VIJAY S · 2008 to 2015
$3.3M
Molecular interactions between soluable host factors and a gene delivery vectorR21AI103692 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI REDDY, VIJAY S · 2013 to 2014
$504k
NIAID NIH HHS R01 AI070771NIAID NIH HHS R21 AI103692NIGMS NIH HHS P41 GM103310NIGMS NIH HHS R01 GM067167
6 · The paper itself

Abstract

Human adenoviruses (HAdVs) cause acute respiratory, ocular, and gastroenteric diseases and are also frequently used as gene and vaccine delivery vectors. Unlike the archetype human adenovirus C5 (HAdV-C5), human adenovirus D26 (HAdV-D26) belongs to species-D HAdVs, which target different cellular receptors, and is differentially recognized by immune surveillance mechanisms. HAdV-D26 is being championed as a lower seroprevalent vaccine and oncolytic vector in preclinical and human clinical studies. To understand the molecular basis for their distinct biological properties and independently validate the structures of minor proteins, we determined the first structure of species-D HAdV at 3.7 Å resolution by cryo-electron microscopy. All the hexon hypervariable regions (HVRs), including HVR1, have been identified and exhibit a distinct organization compared to those of HAdV-C5. Despite the differences in the arrangement of helices in the coiled-coil structures, protein IX molecules form a continuous hexagonal network on the capsid exterior. In addition to the structurally conserved region (3 to 300) of IIIa, we identified an extra helical domain comprising residues 314 to 390 that further stabilizes the vertex region. Multiple (two to three) copies of the cleaved amino-terminal fragment of protein VI (pVIn) are observed in each hexon cavity, suggesting that there could be ≥480 copies of VI present in HAdV-D26. In addition, a localized asymmetric reconstruction of the vertex region provides new details of the three-pronged "claw hold" of the trimeric fiber and its interactions with the penton base. These observations resolve the previous conflicting assignments of the minor proteins and suggest the likely conservation of their organization across different HAdVs.

Indexed as

Adenoviruses, HumanCapsidCapsid ProteinsCryoelectron MicroscopyHumansProtein DomainsCapsid ProteinsAd26Cement proteinsCryo-electron microscopyHAdV-D26Human adenovirus D26Major capsid proteinsMinor capsid proteinsStructure

Identifiers

PMID28508067
PMCPMC5425241

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.